MTOR and Cognitive impairment: The epigenetic disruption of RSK-mTOR-S6K signaling is involved in cognitive defects by loss of Phf8 and that the FDA-approved mTOR inhibitor rapamycin can rescue the behavioral and LTP deficits caused by Phf8 deletion.